GATA4 loss-of-function mutations in familial atrial fibrillation

Clinica Chimica Acta

Volumn 412, Issue 19-20, 2011, Pages 1825-1830

  Yang, Yi Qing ^a   Wang, Mao Ya ^a   Zhang, Xian Ling ^a   Tan, Hong Wei ^a   Shi, Hai Feng ^a   Jiang, Wei Feng ^a   Wang, Xin Hua ^a   Fang, Wei Yi ^a   Liu, Xu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Genetics; Transcription factor

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GATA4 GENE; GENE; GENETIC TRANSCRIPTION; GENOTYPE; HEART ATRIUM FIBRILLATION; HETEROZYGOSITY; HUMAN; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; MUTANT; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PENETRANCE; PRIORITY JOURNAL;

ANIMALS; ATRIAL FIBRILLATION; BASE SEQUENCE; CASE-CONTROL STUDIES; CERCOPITHECUS AETHIOPS; COS CELLS; DNA PRIMERS; FEMALE; GATA4 TRANSCRIPTION FACTOR; GENES, REPORTER; HETEROZYGOTE; HUMANS; LUCIFERASES; MALE; MUTATION; PEDIGREE;

EID: 79960637374     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.06.017     Document Type: Article

References (60)

1. Fuster V., Rydén L.E., Cannom D.S., et al. 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011, 123:e269-e367.
2. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001, 285:2370-2375.
3. Lloyd-Jones D.M., Wang T.J., Leip E.P., et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004, 110:1042-1046.
4. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991, 22:983-988.
5. Benjamin E.J., Wolf P.A., D'Agostino R.B., Silbershatz H., Kannel W.B., Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998, 98:946-952.
6. Roy D., Talajic M., Dubuc M., et al. Atrial fibrillation and congestive heart failure. Curr Opin Cardiol 2009, 24:29-34.
7. Darbar D., Herron K.J., Ballew J.D., et al. Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol 2003, 41:2185-2192.
8. Ellinor P.T., Yoerger D.M., Ruskin J.N., MacRae C.A. Familial aggregation in lone atrial fibrillation. Hum Genet 2005, 118:179-184.
9. Arnar D.O., Thorvaldsson S., Manolio T.A., et al. Familial aggregation of atrial fibrillation in Iceland. Eur Heart J 2006, 27:708-712.
10. Junttila M.J., Raatikainen M.J., Perkiömäki J.S., Hong K., Brugada R., Huikuri H.V. Familial clustering of lone atrial fibrillation in patients with saddleback-type ST-segment elevation in right precordial leads. Eur Heart J 2007, 28:463-468.
11. Christophersen I.E., Ravn L.S., Budtz-Joergensen E., et al. Familial aggregation of atrial fibrillation: a study in Danish twins. Circ Arrhythm Electrophysiol 2009, 2:378-383.
12. Yang Y.Q., Zhang X.L., Wang X.H., et al. Familial aggregation of lone atrial fibrillation in the Chinese population. Intern Med 2010, 49:2385-2391.
13. Lubitz S.A., Yin X., Fontes J.D., et al. Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. JAMA 2010, 304:2263-2269.
14. Fox C.S., Parise H., D'Agostino R.B., et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 2004, 291:2851-2855.
15. Chen Y.H., Xu S.J., Bendahhou S., et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003, 299:251-254.
16. Yang Y., Xia M., Jin Q., et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet 2004, 75:899-905.
17. Olson T.M., Michels V.V., Ballew J.D., et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 2005, 293:447-454.
18. Hong K., Bjerregaard P., Gussak I., Brugada R. Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc Electrophysiol 2005, 16:394-396.
19. Xia M., Jin Q., Bendahhou S., et al. A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun 2005, 332:1012-1019.
20. Gollob M.H., Jones D.L., Krahn A.D., et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 2006, 354:2677-2688.
21. Olson T.M., Alekseev A.E., Liu X.K., et al. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet 2006, 15:2185-2191.
22. Lundby A., Ravn L.S., Svendsen J.H., Hauns S., Olesen S.P., Schmitt N. KCNE3 mutation V17M identified in a patient with lone atrial fibrillation. Cell Physiol Biochem 2008, 21:47-54.
23. Ravn L.S., Aizawa Y., Pollevick G.D., et al. Gain of function in IKs secondary to a mutation in KCNE5 associated with atrial fibrillation. Heart Rhythm 2008, 5:427-435.
24. Hodgson-Zingman D.M., Karst M.L., Zingman L.V., et al. Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N Engl J Med 2008, 359:158-165.
25. Ren X., Xu C., Zhan C., et al. Identification of NPPA variants associated with atrial fibrillation in a Chinese GeneID population. Clin Chim Acta 2010, 411:481-485.
26. Zhang X., Chen S., Yoo S., et al. Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death. Cell 2008, 135:1017-1027.
27. Watanabe H., Darbar D., Kaiser D.W., et al. Mutations in sodium channel beta1- and beta2-subunits associated with atrial fibrillation. Circ Arrhythm Electrophysiol 2009, 2:268-275.
28. Wang P., Yang Q., Wu X., et al. Functional dominant-negative mutation of sodium channel subunit gene SCN3B associated with atrial fibrillation in a Chinese GeneID population. Biochem Biophys Res Commun 2010, 398:98-104.
29. Thibodeau I.L., Xu J., Li Q., et al. Paradigm of genetic mosaicism and lone atrial fibrillation: physiological characterization of a connexin 43-deletion mutant identified from atrial tissue. Circulation 2010, 122:236-244.
30. Brugada R., Tapscott T., Czernuszewicz G.Z., et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997, 336:905-911.
31. Ellinor P.T., Shin J.T., Moore R.K., Yoerger D.M., MacRae C.A. Locus for atrial fibrillation maps to chromosome 6q14-16. Circulation 2003, 107:2880-2883.
32. Oberti C., Wang L., Li L., et al. Genome-wide linkage scan identifies a novel genetic locus on chromosome 5p13 for neonatal atrial fibrillation associated with sudden death and variable cardiomyopathy. Circulation 2004, 110:3753-3759.
33. Volders P.G., Zhu Q., Timmermans C., et al. Mapping a novel locus for familial atrial fibrillation on chromosome10p11-q21. Heart Rhythm 2007, 4:469-475.
34. Nemer M. Genetic insights into normal and abnormal heart development. Cardiovasc Pathol 2008, 17:48-54.
35. Bruneau B.G. The developmental genetics of congenital heart disease. Nature 2008, 451:943-948.
36. Pikkarainen S., Tokola H., Kerkelä R., Ruskoaho H. GATA transcription factors in the developing and adult heart. Cardiovasc Res 2004, 63:196-207.
37. White R.A., Dowler L.L., Pasztor L.M., et al. Assignment of the transcription factor GATA4 gene to human chromosome 8 and mouse chromosome 14: Gata4 is a candidate gene for Ds (disorganization). Genomics 1995, 27:20-26.
38. Maitra M., Schluterman M.K., Nichols H.A., et al. Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development. Dev Biol 2009, 326:368-377.
39. Pu W.T., Ishiwata T., Juraszek A.L., Ma Q., Izumo S. GATA4 is a dosage-sensitive regulator of cardiac morphogenesis. Dev Biol 2004, 275:235-244.
40. Watt A.J., Battle M.A., Li J., Duncan S.A. GATA4 is essential for formation of the proepicardium and regulates cardiogenesis. Proc Natl Acad Sci USA 2004, 101:12573-12578.
41. Garg V., Kathiriya I.S., Barnes R., et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 2003, 424:443-447.
42. Chen Y., Mao J., Sun Y., et al. A novel mutation of GATA4 in a familial atrial septal defect. Clin Chim Acta 2010, 411:1741-1745.
43. Nemer G., Fadlalah F., Usta J., et al. A novel mutation in the GATA4 gene in patients with Tetralogy of Fallot. Hum Mutat 2006, 27:293-294.
44. Rajagopal S.K., Ma Q., Obler D., et al. Spectrum of heart disease associated with murine and human GATA4 mutation. J Mol Cell Cardiol 2007, 43:677-685.
45. Posch M.G., Boldt L.H., Polotzki M., et al. Mutations in the cardiac transcription factor GATA4 in patients with lone atrial fibrillation. Eur J Med Genet 2010, 53:201-203.
46. Brewer A., Pizzey J. GATA factors in vertebrate heart development and disease. Expert Rev Mol Med 2006, 8:1-20.
47. Posch M.G., Perrot A., Berger F., Ozcelik C. Molecular genetics of congenital atrial septal defects. Clin Res Cardiol 2010, 99:137-147.
48. Shiojima I., Komuro I., Oka T., et al. Context-dependent transcriptional cooperation mediated by cardiac transcription factors Csx/Nkx2.5 and GATA-4. J Biol Chem 1999, 274:8231-8239.
49. Mommersteeg M.T., Brown N.A., Prall O.W., et al. Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circ Res 2007, 101:902-909.
50. Zhu W., Shiojima I., Hiroi Y., et al. Functional analyses of three Csx/Nkx-2.5 mutations that cause human congenital heart disease. J Biol Chem 2000, 275:35291-35296.
51. Haïssaguerre M., Jaïs P., Shah D.C., et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998, 339:659-666.
52. Nattel S. Basic electrophysiology of the pulmonary veins and their role in atrial fibrillation: precipitators, perpetuators, and perplexers. J Cardiovasc Electrophysiol 2003, 14:1372-1375.
53. Mommersteeg M.T., Hoogaars W.M., Prall O.W., et al. Molecular pathway for the localized formation of the sinoatrial node. Circ Res 2007, 100:354-362.
54. Gutierrez-Roelens I., De Roy L., Ovaert C., et al. A novel CSX/NKX2-5 mutation causes autosomal-dominant AV block: are atrial fibrillation and syncopes part of the phenotype?. Eur J Hum Genet 2006, 14:1313-1316.
55. Watanabe Y., Benson D.W., Yano S., Akagi T., Yoshino M., Murray J.C. Two novel frameshift mutations in NKX2.5 result in novel features including visceral inversus and sinus venosus type ASD. J Med Genet 2002, 39:807-811.
56. Pabst S., Wollnik B., Rohmann E., et al. A novel stop mutation truncating critical regions of the cardiac transcription factor NKX2-5 in a large family with autosomal-dominant inherited congenital heart disease. Clin Res Cardiol 2008, 97:39-42.
57. Gruver E.J., Fatkin D., Dodds G.A., et al. Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation. Am J Cardiol 1999, 83:13H-18H.
58. Firouzi M., Bierhuizen M.F., Kok B., et al. The human Cx40 promoter polymorphism -44G->A differentially affects transcriptional regulation by Sp1 and GATA4. Biochim Biophys Acta 2006, 1759:491-496.
59. Yang Y.Q., Zhang X.L., Wang X.H., et al. Connexin40 nonsense mutation in familial atrial fibrillation. Int J Mol Med 2010, 26:605-610.
60. Yang Y.Q., Liu X., Zhang X.L., et al. Novel connexin40 missense mutations in patients with familial atrial fibrillation. Europace 2010, 12:1421-1427.